Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas Meeting Abstract


Authors: O'Connor, O. A.; Hamlin, P.; Moskowitz, C.; Portlock, C.; Sarasohn, D.; Dumitrescu, O.; Neylon, E.; Patterson, M.; Zelenetz, A.; Saunders, M.; Cagnoni, P.; Mould, D.; Fleisher, M.; Califano, A.; Sirotnak, F.; Horwitz, S.
Abstract Title: Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas
Meeting Title: 10th International Conference on Malignant Lymphoma
Journal Title: Annals of Oncology
Volume: 19
Issue: Suppl.4
Meeting Dates: 2008 Jun 4-7
Meeting Location: Lugano, Switzerland
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2008-06-01
Start Page: 128
Language: English
ACCESSION: WOS:000256693500155
PROVIDER: wos
DOI: 10.1093/annonc/mdn230
Notes: --- - Meeting Abstract: 138 - 10th International Conference on Malignant Lymphoma - JUN 04-07, 2008 - Lugano, SWITZERLAND - "4" - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carol Portlock
    204 Portlock
  2. Craig Moskowitz
    407 Moskowitz
  3. Steven M Horwitz
    645 Horwitz
  4. Andrew D Zelenetz
    767 Zelenetz
  5. Paul Hamlin
    277 Hamlin
  6. Martin Fleisher
    312 Fleisher
  7. Francis M Sirotnak
    184 Sirotnak